Effect of caffeine administration in prevention of bronchopulmonary dysplasia (BPD)

Phase 2

• Conditions: P27.1; Bronchopulmonary dysplasia.; Bronchopulmonary dysplasia originating in the perinatal period

• Registration Number: IRCT20160827029535N8
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

The preterm neonates with gestational age of 35 weeks or less
The preterm neonates with birth weight of 1500 grams or less

Exclusion Criteria

The preterm neonates with any underlying condition (e.g. gastrointestinal anomalies, neurological disorders)
The preterm neonates with history of receiving any maternal or neonatal relaxant or sedative medications before intervention.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bronchopulmonary dysplasia of preterm neonates. Timepoint: Before intervention and two weeks after the end of intervention (the end of the 36th week of corrected gestational age). Method of measurement: Clinical manifestations and chest-xray findings.